Canadian Biopharma Stock Surges on Mexican Agreement

Tetra Bio-Pharma Inc. (TSXV:TBP), a Canadian biopharma stock, climbed after signing a co-development and commercialization agreement with Alternavida S.A. de C.V.

Sean Mason | December 2, 2019 | SmallCapPower

A cannabinoid-based pain drug development deal lifted a Canadian biopharma stock Monday. Here’s some small stocks making big moves on Monday, December 2, 2019 (as of 4 pm EST):

Tetra Bio-Pharma Inc. (TSXV:TBP), a Canadian biopharma stock, powered 35% higher to $0.50 on Monday after announcing that it has signed a definitive co-development and commercialization agreement with Alternavida S.A. de C.V. for the clinical development, marketing and distribution of CAUMZ, a cannabinoid-derived therapeutic composed of pure synthetic THC and CBD for use in treatment of chronic pain, in Mexico. Tetra will receive a one-time license fee of C$125,000 as well as royalties on CAUMZ sales in Mexico of 10% in year one, 12.5% in year two, and 15% in years three to 15.

Win Big With Our Small Cap Picks

 

As well, shares of Centerra Gold Inc. (TSX:CG) slipped 11% to $10.06 as the gold miner said two of its employees are missing following what it called a “significant rock movement” at its Kumtor Mine in the Kyrgyz Republic.

Continental Gold Inc. (TSX:CNL), meanwhile, reported that it has agreed to be acquired by Zijin Mining Group Co., Ltd. at a price of C$5.50 per share in cash, or a total consideration of approximately C$1.4 billion on a fully-diluted basis. Continental Gold stock moved up 11% to $5.39 following the announcement.

See more Small and Micro Cap Market Movers Daily from Sean Mason. Tomorrow’s big stock market winners could be found here today!

Hi, did you know SmallCapPower accepts blog submissions? You can contact me here

Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.

To read our full disclosure, please click on the button below: